Skip to main content

Advertisement

SpringerLink
Log in

Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

The main purpose was to assess the effect of c.29C>T and c.74G>C polymorphisms in the TGFB1 signal peptide on HPV infection and development of cervical lesions. Cervical swabs and blood samples were obtained from 349 outpatient women, along with socio-demographic and sexual behavioral data. The study population was stratified by absence or presence of HPV DNA, as tested by PCR, as well as by lesion grade. TGFB1 signal peptide polymorphisms were genotyped using PCR-restriction fragment length polymorphism. HPV DNA was detected in 172 (49.3%) patients. c.74GC and the combined c.29CC+CT/c.74GC genotype were more frequent in infected patients (35.1 and 15.7%) than in uninfected women (6.2 and 14.7%). Accordingly, these genotypes were associated with a higher risk of HPV infection, with odds ratio and 95% confidence interval of 2.81 and 1.35–5.86 (P = 0.004) for c.74GC and 3.14 and 1.42–6.94 (P = 0.004) for the combined genotype, respectively. High-grade lesions were also 2.48 times more likely to occur in c.29CC patients than in c.29TT patients, with a 95% confidence interval of 1.01–6.08 (P = 0.047). The data demonstrate that c.74G>C and c.29C>T polymorphisms are significantly associated with risk of HPV infection and high-grade squamous intraepithelial lesions, respectively. Thus, TGFB1 signal peptide polymorphisms are potential susceptibility markers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    Article  CAS  PubMed  Google Scholar 

  2. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632

    Article  CAS  PubMed  Google Scholar 

  3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890–907

    Article  CAS  PubMed  Google Scholar 

  4. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13:857–861

    Article  CAS  PubMed  Google Scholar 

  5. zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690–698

    Article  CAS  PubMed  Google Scholar 

  6. Castellsagué X, Muñoz N (2003) Chap. 3: Cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 20–28

  7. Patel S, Chiplunkar S (2009) Host immune responses to cervical cancer. Curr Opin Obstet Gynecol 21:54–59

    Article  PubMed  Google Scholar 

  8. Alcocer-González JM, Berumen J, Taméz-Guerra R, Bermúdez-Morales V, Peralta-Zaragoza O, Hernández-Pando R, Moreno J, Gariglio P, Madrid-Marina V (2006) In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 19:481–491

    Article  PubMed  Google Scholar 

  9. Guan X, Sturgis EM, Lei D, Liu Z, Dahlstrom KR, Wei Q, Li G (2010) Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res 16:1416–1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lebrun J-J (2012) The dual role of TGFβ in human cancer: from tumor suppression to cancer metastasis. ISRN Mol Biol 381428

  11. Zarzynska JM (2014) Two faces of TGF-beta1 in breast cancer. Mediators Inflamm 141747

  12. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC (2003) A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63:2610–2615

    CAS  PubMed  Google Scholar 

  13. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Specter TD (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93–97

    Article  CAS  PubMed  Google Scholar 

  14. Healy J, Dionne J, Bélanger H, Lariviere M, Beaulieu P, Labuda D, Sinnett D (2009) Functional impact of sequence variation in the promoter region of TGFB1. Int J Cancer 125:1483–1489

    Article  CAS  PubMed  Google Scholar 

  15. Shah R, Rahaman B, Hurley CK, Posch PE (2006) Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 119:61–74

    Article  CAS  PubMed  Google Scholar 

  16. Wood NA, Thomson SC, Smith RM, Bidwell JL (2000) Identification of human TGF-beta1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 234:117–122

    Article  CAS  PubMed  Google Scholar 

  17. Martelossi Cebinelli GC, Paiva Trugilo K, Badaró Garcia S, Brajão de Oliveira K (2016) TGF-1 functional polymorphisms: a review. Eur Cytokine Netw 27:81–89

    PubMed  Google Scholar 

  18. Pooja S, Francis A, Rajender S, Tamang R, Rajkumar R, Saini KS, Megu K, Goel MM, Surekha D, Rao DR, Rao L, Ramachandra L, Kumar S, Kumar S, Vishnupriya S, Satyamoorthy K, Negi MP, Thangaraj K, Konwar R (2013) Strong impact of TGF-β1 gene polymorphisms on breast cancer risk in Indian women: a case-control and population-based study. PLoS One 8:e75979

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Shin A, Shu XO, Cai Q, Gao YT, Zheng W (2005) Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 14:1567–1570

    Article  CAS  PubMed  Google Scholar 

  20. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS (2001) Association between the T29> C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: the study of osteoporotic fractures. JAMA 285:2859–2863

    Article  CAS  PubMed  Google Scholar 

  21. Carneiro NK, Oda JMM, Losi-Guembarovski R, Ramos G, Oliveira BV, Cavalli IJ, de SF Ribeiro, Gonçalves EM, Watanabe MS MAE (2013) Possible association between TGF-β1 polymorphism and oral cancer. Int J Immunogenet 40:292–298

    Article  CAS  PubMed  Google Scholar 

  22. Fan H, Yu H, Deng H, Chen X (2014) Transforming growth factor-β1 rs1800470 polymorphism is associated with lung cancer risk: a meta-analysis. Med Sci Monit 20:2358–2362

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lima SF, Tavares MMF, Macedo JL, Oliveira RS, Heráclio SA, Maia MMD, Souza PRE, Moura R, Crovella S (2016) Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil. Mem Inst Oswaldo Cruz 111:663–669

    Article  CAS  Google Scholar 

  24. Marangon AV, Guelsin GAS, Visentainer JEL, Borelli SD, Watanabe MAE, Consolaro MEL, Caleffi-Ferracioli KR, Rudnick CCC, Sell AM (2013) The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population. Biomed Res Int 146079

  25. Fernandes APM, Gonçalves MAG, Simões RT, Mendes-Junior CT, Duarte G, Donadi EA (2008) A pilot case–control association study of cytokine polymorphisms in Brazilian women presenting with HPV-related cervical lesions. Eur J Obstet Gynecol Reprod Biol 140:241–244

    Article  CAS  PubMed  Google Scholar 

  26. Wang Q, Zhang C, Walayat S, Chen HW, Wang Y (2011) Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol 158:330–333

    Article  CAS  PubMed  Google Scholar 

  27. Stanczuk GA, Tswana SA, Bergstrom S, Sibanda EM (2002) Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-β1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur J Immunogenet 29:417–421

    Article  CAS  PubMed  Google Scholar 

  28. da Silva MC, Martins HP, de Souza JL, Tognim MCB, Svidzinski TIE, Teixeira JJV, Consolaro MEL (2012) Prevalence of HPV infection and genotypes in women with normal cervical cytology in the state of Paraná, Brazil. Arch Gynecol Obstet 286:1015–1022

    Article  PubMed  Google Scholar 

  29. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM (1991) Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472–477

    Article  CAS  PubMed  Google Scholar 

  30. Coser J, da Rocha Boeira T, Wolf JM, Cerbaro K, Simon D, Lunge VR (2016) Cervical human papillomavirus infection and persistence: a clinic-based study in the countryside from South Brazil. Braz J Infect Dis 20:61–68

    Article  PubMed  Google Scholar 

  31. Hwang LY, Lieberman JA, Ma Y, Farhat S, Moscicki AB (2012) Cervical ectopy and the acquisition of human papillomavirus in adolescents and young women. Obstet Gynecol 119:1164–1170

    Article  PubMed  PubMed Central  Google Scholar 

  32. Nunes JD, Vidal FC, Ferraro CT, Chein MBC, Brito LMO, Monteiro SCM (2014) Molecular detection of human papillomavirus in Brazilian women with cervical intraepithelial neoplasia in a northeast Brazilian city. Genet Mol Res 13:9077–9085

    Article  CAS  PubMed  Google Scholar 

  33. Alam S, Conway MJ, Chen HS, Meyers C (2007) The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol 82:1053–1058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Castellsagué X, Bosch FX, Muñoz N (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89:191–199

    Article  PubMed  Google Scholar 

  35. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang X, Waggoner S (1999) Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett 146:127–134

    Article  CAS  PubMed  Google Scholar 

  36. Torres-Poveda K, Bahena-Román M, Madrid-González C, Burguete-García AI, Bermúdez-Morales VH, Peralta-Zaragoza O, Madrid-Marina V (2014) Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia. World J Clin Oncol 5:753–763

    Article  PubMed  PubMed Central  Google Scholar 

  37. Crawford DC, Nickerson DA (2005) Definition and clinical importance of haplotypes. Annu Rev Med 56:303–320

    Article  CAS  PubMed  Google Scholar 

  38. Ki K-D, Tong S-Y, Huh C-Y, Lee JM, Lee SK, Chi SG (2009) Expression and mutational analysis of TGF-beta/Smads signaling in human cervical cancers. J Gynecol Oncol 20:117–121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Peghini BC, Abdalla DR, Barcelos ACM, Teodoro LDGVL, Murta EFC, Michelin MA (2012) Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia. Hum Immunol 73:920–926

    Article  CAS  PubMed  Google Scholar 

  40. Xu Q, Wang S, Xi L, Wu S, Chen G, Zhao Y, Wu Y, Ma D (2006) Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway. Gynecol Oncol 101:132–139

    Article  CAS  PubMed  Google Scholar 

  41. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV (1998) Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66:1014–1020

    Article  CAS  PubMed  Google Scholar 

  42. Gu X, Ji X, Shi L-H, Yi CH, Zhao YP, Wang AH, Lu LG, Yu WB, Gao CF (2012) Transforming growth factor beta1 gene variation Leu10Pro affects secretion and function in hepatic cells. Dig Dis Sci 57:2901–2909

    Article  CAS  PubMed  Google Scholar 

  43. Guo W, Dong Z, Guo Y, Chen Z, Yang Z, Kuang G, Shan B (2011) Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China. Int J Immunogenet 38:215–224

    Article  CAS  PubMed  Google Scholar 

  44. Taubenschuß E, Marton E, Mogg M, Frech B, Ehart L, Muin D, Schreiber M (2013) The L10P polymorphism and serum levels of transforming growth factor β1 in human breast cancer. Int J Mol Sci 14:15376–15385

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y (2000) Association of a T29> C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101:2783–2787

    Article  CAS  PubMed  Google Scholar 

  46. Woodworth CD, Notario V, DiPaolo JA (1990) Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 64:4767–4775

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46–53

    Article  CAS  PubMed  Google Scholar 

  48. Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limón P (2010) The polarization of immune cells in the tumour environment by TGF beta. Nat Rev Immunol 10:554–567

    Article  CAS  PubMed  Google Scholar 

  49. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM (2003) Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9:194–202

    Article  CAS  PubMed  Google Scholar 

  51. Luo Q, Zhang S, Wei H, Pang X, Zhang H (2015) Roles of Foxp3 in the occurrence and development of cervical cancer. Int J Clin Exp Pathol 8:8717–8730

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the volunteers who participated in the study, the Intermunicipal Consortium of Health of the Middle Paranapanema, the University Hospital and Clinic Center of State University of Londrina, the Municipal Health Department of Londrina, Londrina—PR, Brazil, and Londrina State University Coordination for Postgraduation.

Funding

This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (470137/2013-4), Fundação Araucária—Programa Pesquisa para o SUS (34935.406.36850.19112012). This work received fellowship support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, and financial support for language editing from FAEPE/UEL-PUBLIC 2016.

Author information

Authors and Affiliations

  1. Department of Pathological Science, Biological Science Center, State University of Londrina, Londrina, Paraná, Brazil

    Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Fernanda Costa Brandão Berti, Nádia Calvo Martins Okuyama, Fernando Cezar-dos-Santos, Michelle Mota Sena, Maria Angelica Ehara Watanabe & Karen Brajão de Oliveira

  2. Department of Gynecology and Obstetrics, Health Science Center, State University of Londrina, Londrina, Paraná, Brazil

    Luis Fernando Lásaro Mangieri

Authors
  1. Kleber Paiva Trugilo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guilherme Cesar Martelossi Cebinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernanda Costa Brandão Berti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nádia Calvo Martins Okuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fernando Cezar-dos-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michelle Mota Sena
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luis Fernando Lásaro Mangieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maria Angelica Ehara Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Karen Brajão de Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen Brajão de Oliveira.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trugilo, K.P., Cebinelli, G.C.M., Berti, F.C.B. et al. Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions. Med Microbiol Immunol 208, 49–58 (2019). https://doi.org/10.1007/s00430-018-0557-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-018-0557-y

Keywords

Search

Navigation